Science Explorer Back to mapMap
Discussion
Company · Rochester · United States

OyaGen (United States)

oyageninc.com/wordpressROR OpenAlex
Research works
10
▼ 92% vs 2018-21
Citations
499
49.9 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
72%
world 40%
International
10%
world 18%
OyaGen (United States)

Not ranked overall: OyaGen (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does OyaGen (United States) work in?

In all years, 56% of research at OyaGen (United States) is in Life Sciences, 38% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (36%), Medicine (34%), Immunology and Microbiology (19%). It does 1.9× the world's share of Life Sciences.

Life Sciences: 6 fractional works · 56.4% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 35.8% of its workMolecular Biology: 4 fractional works · 35.8% of its workImmunology and Microbiology: 2 fractional works · 19.4% of its workVirology: 1 fractional works · 14.4% of its workImmunology: 0 fractional works · 5.0% of its workAgricultural and Biological Sciences: 0 fractional works · 1.1% of its workPlant Science: 0 fractional works · 1.1% of its workHealth Sciences: 4 fractional works · 37.5% of its workMedicine: 3 fractional works · 34.2% of its workInfectious Diseases: 2 fractional works · 18.1% of its workEpidemiology: 1 fractional works · 10.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 2.5% of its workHepatology: 0 fractional works · 1.7% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.7% of its workHealth Professions: 0 fractional works · 3.3% of its workEmergency Medical Services: 0 fractional works · 3.3% of its workPhysical Sciences: 1 fractional works · 6.1% of its workEngineering: 0 fractional works · 3.3% of its workAerospace Engineering: 0 fractional works · 1.7% of its workMechanical Engineering: 0 fractional works · 1.7% of its workMaterials Science: 0 fractional works · 1.7% of its workMaterials Chemistry: 0 fractional works · 1.7% of its workEnvironmental Science: 0 fractional works · 1.1% of its workEcology: 0 fractional works · 1.1% of its workALL ITS WORKOyaGen (UnitedStates)10fractional works, all years
Life Sciences56%Physical Sciences6%Health Sciences38%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 8 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology435.8%
    2. Immunology and Microbiology219.4%
    3. Agricultural and Biological Sciences01.1%
    1. Medicine334.2%
    2. Health Professions03.3%
    1. Engineering03.3%
    2. Materials Science01.7%
    3. Environmental Science01.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from OyaGen (United States)?

The most cited paper from OyaGen (United States) is "The APOBEC Protein Family: United by Structure, Divergent in Function" (Jason D. Salter, Ryan P. Bennett, Harold C. Smith, 2016), with 429 citations. Next come "Modeling the Embrace of a Mutator: APOBEC Selection of Nucleic Acid Ligands" (75) and "The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions" (63).

Most cited papers
#PaperReleasedCitations
1 The APOBEC Protein Family: United by Structure, Divergent in Function Jason D. Salter, Ryan P. Bennett, Harold C. Smith · Trends in Biochemical Sciences ReviewOpen access 6 Jun 2016 429
2 Modeling the Embrace of a Mutator: APOBEC Selection of Nucleic Acid Ligands Jason D. Salter, Harold C. Smith · Trends in Biochemical Sciences ReviewOpen access 23 May 2018 75
3 The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions Kimberly M. Prohaska, Ryan P. Bennett, Jason D. Salter et al. · Wiley Interdisciplinary Reviews - RNA ReviewOpen access 24 Mar 2014 63
4 The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G James H Miller, Vladimir Presnyak, Harold C. Smith · Retrovirology Open access 24 Nov 2007 57
5 HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-Competent and Multi-Drug-Resistant HIV in Human Cells Thomas A. Hilimire, Jeffrey M. Chamberlain, Viktoriya S. Anokhina et al. · ACS Chemical Biology Open access 27 Apr 2017 53
All 20 most cited papers, with filters and sorting

Which research topics does OyaGen (United States) publish most on?

By volume in 2022-now: Viral gastroenteritis research and epidemiology, SARS-CoV-2 and COVID-19 Research and Viral Infections and Immunology Research.

Viral gastroenteritis re…0Viral gastroenteritis research and epidemiology: 0 fractional worksSARS-CoV-2 and COVID-19 …0SARS-CoV-2 and COVID-19 Research: 0 fractional worksViral Infections and Imm…0Viral Infections and Immunology Research: 0 fractional works
Infectious DiseasesCardiology and Cardiovascular Medicine

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
  2. 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  3. 3 Viral Infections and Immunology Research Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available71.7%not open28.3%

World: 40% of research is openly available.

with international co-authors10.0%domestic only90.0%

World: 18% is written across borders.

How has OyaGen (United States)'s research output changed?

Output in 2022-2025 was 92% lower than in 2018-2021.

201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is OyaGen (United States) as a percentage of every work published that year, 0.000016% in 2021.

0.00010%0.00020%OyaGen (United States)0.0000046% in 202319801990200020102020

Fractional works of OyaGen (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Rochester

All research institutions in Rochester

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about OyaGen (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.